Objective: Juvenile Nasopharyngeal Angiofibroma (JNA) is a benign neoplasm with a high vascularity component, greater craniofacial involvement in adolescent patients, and aggressive local behaviour. In unresectable patients, radiotherapy is a therapeutic option for local control. Our aim in this study was to analyze the clinical benefit and local control provided by two modalities of radiotherapy: the Three-Dimensional Conformal (3DC) technique and volumetric modulated arc therapy (VMAT), applied to pediatric patients with JNA considered unresectable and non-recurrent. Methods: In retrospective study, the information was recorded from pediatric patients with a diagnosis of non-recurrent and unresectable JNA treated with radiotherapy at the Oncology Hospital of the National Medical Center SXXI of Mexico City, from March 2010 to March 2021. Radiotherapy management and its association with clinical outcomes of tumour control, and symptoms were assessed. In addition, an evaluation of acute and chronic toxicity was performed. Results: It was found that the median age was 14 years. 9 patients (37.5%) underwent 3DC and 15 (62.5%) VMAT. In terms of local control, and progression-free survival, we did not find significant difference between radiotherapy modalities (p ≤ 0.57). Acute toxicity for both modalities presented statistical differences for radio epithelitis (p = 0.03). Only Grade I and II radiation-induced acute toxicity was observed. Regarding chronic toxicity, statistical significance was observed for craniofacial hypoplasia, in relation to its absence in the VMAT group (p = 0.001). Conclusion: The VMAT presents improvements in dosimetry parameters that improve patient toxicity. In both techniques adequate tumour control was observed, however, the rarity of the disease is a limitation to establish the most appropriate therapeutic technique.
References
[1]
Singh, R.K., Lakhkar, B.B., Patwa, P.A. and Mishra, G.V. (2022) Juvenile Nasopharyngeal Angiofibroma. BMJ Case Reports, 15, e248023. https://doi.org/10.1136/bcr-2021-248023
[2]
Rahmadiyanto, Y. and Romdhoni, A.C. (2022) Multidiscipline Management of Giant Reccurent Nasopharyngeal Angiofibroma Which Extends to Paranasal Sinuses, Orbita, and Intracranial in Adult. International Journal of Surgery Case Reports, 99, Article ID: 107579. https://doi.org/10.1016/j.ijscr.2022.107579
[3]
Reddy, K.A., Mendenhall, W.M., Amdur, R.J., Stringer, S.P. and Cassisi, N.J. (2001) Long-Term Results of Radiation Therapy for Juvenile Nasopharyngeal Angiofibroma. American Journal of Otolaryngology, 22, 172-175. https://doi.org/10.1053/ajot.2001.23458
[4]
Lee, J.T., Chen, P., Safa, A., Juillard, G. and Calcaterra, T.C. (2002) The Role of Radiation in the Treatment of Advanced Juvenile Angiofibroma. Laryngoscope, 112, 1213-1220. https://doi.org/10.1097/00005537-200207000-00014
[5]
Fagan, J.J., Snyderman, C.H., Carrau, R.L. and Janecka, I.P. (1997) Nasopharyngeal Angiofibromas: Selecting a Surgical Approach. Head Neck, 19, 391-399. https://doi.org/10.1002/(SICI)1097-0347(199708)19:5<391::AID-HED5>3.0.CO;2-V
[6]
Vlaescu, A.N., Ionita, E., Ciolofan, M.S., Mogoanta, C.A., Voiosu, C., Rusescu, A., et al. (2022) Current Approach of Juvenile Nasopharyngeal Angiofibroma: A Case Series. Romanian Journal of Morphology and Embryology, 63, 105-111. https://doi.org/10.47162/RJME.63.1.10
[7]
Longacre, M.M., Seshadri, S.C., Adil, E., Baird, L.C. and Goobie, S.M. (2023) Perioperative Management of Pediatric Patients Undergoing Juvenile Angiofibroma Resection. A Case Series and Educational Review Highlighting Patient Blood Management. Pediatric Anesthesia, 33, 510-519. https://doi.org/10.1111/pan.14655
[8]
Enepekides, D.J. (2004) Recent Advances in the Treatment of Juvenile Angiofibroma. Current Opinion in Otolaryngology & Head and Neck Surgery, 12, 495-499. https://doi.org/10.1097/01.moo.0000143970.19992.64
[9]
Camilon, P.R., Rahbar, R., Cunningham, M.J. and Adil, E.A. (2019) Juvenile Nasopharyngeal Angiofibroma in Prepubertal Males: A Diagnostic Dilemma. Laryngoscope, 129, 1777-1783. https://doi.org/10.1002/lary.27633
[10]
Tork, C.A. and Simpson, D.L. (2023) Nasopharyngeal Angiofibroma. Stat Pearls, Treasure Island.
[11]
Patil, R.N., Agarwal, A.K., Prakash, B. and Ghosh, P. (1982) Extra-Nasopharyngeal Extensions of Angiofibroma. The Journal of Laryngology & Otology, 96, 1053-1064. https://doi.org/10.1017/S002221510009349X
[12]
Ramos, H.F., Takahashi, M.T., Ramos, B.F., Gomes Mde, Q. and Sennes, L.U. (2011) Juvenile Nasopharyngeal Angiofibroma with Intradural Extension. Brazilian Journal of Otorhinolaryngology, 77, 677. https://doi.org/10.1590/S1808-86942011000500025
[13]
Golabek, W., Szymanska, A., Szymanski, M., Czekajska-Chehab, E. and Jargiello, T. (2019) Juvenile Nasopharyngeal Angiofibroma with Intracranial Extension—Diagnosis and Treatment. Polish Journal of Otolaryngology, 74, 1-7. https://doi.org/10.5604/01.3001.0013.5275
[14]
Maroda, A.J., Beckmann, N.A., Sheyn, A.M., Elijovich, L., Michael, L.M., DiNitto, J.M., et al. (2020) Trimodal Embolization of Juvenile Nasopharyngeal Angiofibroma with Intracranial Extension. International Journal of Pediatric Otorhinolaryngology, 130, Article ID: 109805. https://doi.org/10.1016/j.ijporl.2019.109805
[15]
Choi, J.S., Yu, J., Lovin, B.D., Chapel, A.C., Patel, A.J. and Gallagher, K.K. (2022) Effects of Preoperative Embolization on Juvenile Nasopharyngeal Angiofibroma Surgical Outcomes: A Study of the Kids’ Inpatient Database. Journal of Neurological Surgery Part B, 83, 76-81. https://doi.org/10.1055/s-0040-1716676
[16]
Mallick, S., Benson, R., Bhasker, S. and Mohanti, B.K. (2015) Long-Term Treatment Outcomes of Juvenile Nasopharyngeal Angiofibroma Treated with Radiotherapy. ACTA Otorhinolaryngologica Italica, 35, 75-79.
[17]
Chakraborty, S., Ghoshal, S., Patil, V.M., Oinam, A.S. and Sharma, S.C. (2011) Conformal Radiotherapy in the Treatment of Advanced Juvenile Nasopharyngeal Angiofibroma with Intracranial Extension: An Institutional Experience. International Journal of Radiation Oncology, Biology, Physics, 80, 1398-1404. https://doi.org/10.1016/j.ijrobp.2010.04.048
[18]
Kuppersmith, R.B., Teh, B.S., Donovan, D.T., Mai, W.Y., Chiu, J.K., Woo, S.Y., et al. (2000) The Use of Intensity Modulated Radiotherapy for the Treatment of Extensive and Recurrent Juvenile Angiofibroma. International Journal of Pediatric Otorhinolaryngology, 52, 261-268. https://doi.org/10.1016/S0165-5876(00)00297-4
[19]
Blank, Z., Sleightholm, R., Neilsen, B., Baine, M. and Lin, C. (2021) Radiation Therapy Improves Local Control in Juvenile Nasopharyngeal Angiofibroma following Disease Progression after Embolization and Surgical Resection: A Case Report. Case Reports in Oncology, 14, 739-745. https://doi.org/10.1159/000512061
[20]
Lopez, F., Triantafyllou, A., Snyderman, C.H., Hunt, J.L., Suarez, C., Lund, V.J., et al. (2017) Nasal Juvenile Angiofibroma: Current Perspectives with Emphasis on Management. Head Neck, 39, 1033-1045. https://doi.org/10.1002/hed.24696
[21]
Parvathaneni, U., Laramore, G.E. and Liao, J.J. (2012) Technical Advances and Pitfalls in Head and Neck Radiotherapy. Journal of Oncology, 2012, Article ID: 597467. https://doi.org/10.1155/2012/597467